Is Beta-Blocker Use Beneficial in Breast Cancer? A Meta-Analysis

Publisher： Karger

E-ISSN： 1423-0232|92|5|264-268

ISSN： 0030-2414

Source： Oncology, Vol.92, Iss.5, 2017-01, pp. : 264-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What Are Hospitals Doing to Increase Beta-Blocker Use?

By Bradley Elizabeth H.   Holmboe Eric S.   Wang Yongfei   Herrin Jeph   Frederick Paul D.   Mattera Jennifer A.   Roumanis Sarah A.   Radford Martha J.   Krumholz Harlan M.  

Joint Commission Journal on Quality and Patient Safety, Vol. 29, Iss. 8, 2003-08 ,pp. : 409-415

Joint Commission Resources

Access to resources Recommend Favorite

Calcium channel blocker use and risk of Parkinson's disease: a meta‐analysis

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 6, 2015-06 ,pp. : 559-566

John Wiley & Sons Inc

Access to resources Recommend Favorite

Appropriate Use of Early Beta-Blocker Therapy in Acute Coronary Syndrome

By  

Cardiology, Vol. 115, Iss. 3, 2010-02 ,pp. : 209-210

Karger

Access to resources Recommend Favorite

Impact of Statin Therapy on Clinical Outcomes in Chronic Heart Failure Patients According to Beta-Blocker Use: Results of CIBIS II

By  

Cardiology, Vol. 108, Iss. 1, 2006-09 ,pp. : 28-34

Karger

Access to resources Recommend Favorite

Bisphosphonate use and the risk of endometrial cancer: a meta‐analysis of observational studies

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 25, Iss. 10, 2016-10 ,pp. : 1107-1115

John Wiley & Sons Inc

Access to resources Recommend Favorite